Quick Takeaways
- This page summarizes Marc N. Casper's Form 4 filing for THERMO FISHER SCIENTIFIC INC. (TMO).
- 8 reported transactions and 0 derivative rows are listed below.
- Filing timestamp: 04 Nov 2022, 16:49.
Quoteable Key Fact
"Marc N. Casper filed Form 4 for THERMO FISHER SCIENTIFIC INC. (TMO) on 04 Nov 2022."
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TMO | Common Stock | Sale | $386,504 | -800 | -0.43% | $483.13 | 185,405 | 03 Nov 2022 | Direct | F1, F2 |
| transaction | TMO | Common Stock | Sale | $160,685 | -332 | -0.18% | $483.99 | 185,073 | 03 Nov 2022 | Direct | F1, F3 |
| transaction | TMO | Common Stock | Sale | $97,092 | -200 | -0.11% | $485.46 | 184,873 | 03 Nov 2022 | Direct | F1, F4 |
| transaction | TMO | Common Stock | Sale | $961,956 | -1,976 | -1.1% | $486.82 | 182,897 | 03 Nov 2022 | Direct | F1, F5 |
| transaction | TMO | Common Stock | Sale | $1,053,756 | -2,160 | -1.2% | $487.85 | 180,737 | 03 Nov 2022 | Direct | F1, F6 |
| transaction | TMO | Common Stock | Sale | $797,999 | -1,632 | -0.9% | $488.97 | 179,105 | 03 Nov 2022 | Direct | F1, F7 |
| transaction | TMO | Common Stock | Sale | $489,990 | -1,000 | -0.56% | $489.99 | 178,105 | 03 Nov 2022 | Direct | F1, F8 |
| transaction | TMO | Common Stock | Sale | $49,074 | -100 | -0.06% | $490.74 | 178,005 | 03 Nov 2022 | Direct | F1 |
| holding | TMO | Common Stock | 2,000 | 02 Nov 2022 | By Alison Casper 2020 Irrevocable Trust | F9 | |||||
| holding | TMO | Common Stock | 89,155 | 02 Nov 2022 | By Floral Park Associates, Inc. |
| Id | Content |
|---|---|
| F1 | The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 26, 2021. |
| F2 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $482.52 to $483.48, inclusive. The reporting person undertakes to provide to Thermo Fisher Scientific Inc. ("TMO"), any security holder of TMO or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (3), (4), (5), (6), (7), and (8) to this Form 4. |
| F3 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $483.64 to $484.44, inclusive. |
| F4 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $485.25 to $485.66, inclusive. |
| F5 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $486.41 to $487.35, inclusive. |
| F6 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $487.42 to $488.32, inclusive. |
| F7 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $488.49 to $489.40, inclusive. |
| F8 | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $489.59 to $490.49, inclusive. |
| F9 | The reporting person disclaims beneficial ownership of the securities reported herein as indirectly beneficially owned, except to the extent of any pecuniary interest therein. |
One of two Form 4's filed on November 4, 2022 for the reporting of transactions occurring on November 2, 2022 and November 3, 2022, both partially included in the first Form 4. The second Form 4 includes additional transactions occurring on November 3, 2022 that could not be included in the first Form 4 due to a limitation on the number of line items that can be included per table in a single Form 4.